
Benefits of Neurohormonal Therapy in Patients With Continuous-Flow Left Ventricular Assist Devices
Author(s) -
Rayan Yousefzai,
Michela Brambatti,
Hao Tran,
Rachel Pedersen,
Öscar Braun,
Tina Baykaner,
Roxana Ghashghaei,
Nasir Sulemanjee,
Omar Cheema,
Matthew Rappelt,
Carmela Baeza,
Abdulaziz Alkhayyat,
Yang Shi,
Victor Pretorius,
Barry Greenberg,
Eric Adler,
Vinay Thohan
Publication year - 2020
Publication title -
asaio journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.961
H-Index - 66
eISSN - 1538-943X
pISSN - 1058-2916
DOI - 10.1097/mat.0000000000001022
Subject(s) - medicine , ejection fraction , cardiology , hazard ratio , heart failure , ventricular assist device , proportional hazards model , heart transplantation , blockade , retrospective cohort study , angiotensin receptor blockers , angiotensin converting enzyme , surgery , confidence interval , receptor , blood pressure